IDEAYA Biosciences (IDYA) Receivables (2020 - 2024)
IDEAYA Biosciences (IDYA) reported Receivables of $3,000 for Q4 2024, down 83.3% from $18,000 a year earlier and down 85.0% from the prior quarter.
Powered by 
Analysis
IDEAYA Biosciences (IDYA) Receivables (2020 - 2024) Analysis & Trends
Dating back to Q4 2020, IDEAYA Biosciences' Receivables record includes 17 quarters.
- Receivables has declined for four consecutive years, with a four-year compound annual growth rate of -80.1% (FY2020 to FY2024).
- By year, Receivables came in at $18,000 in FY2023 (-91.5%), $211,000 in FY2022 (-80.9%), $1.1 million in FY2021 (-41.9%) and $1.9 million in FY2020.
- Five-year quarterly Receivables spans a low of $1,000 in Q2 2024 and a high of $6.7 million in Q3 2023.
- Year over year, Receivables has now declined in each of the last five quarters, with an average decline of 56.6% over the last eight quarters.
- The high point for year-over-year Receivables in five years was Q3 2022 (growth of 238.8%); the low point was Q3 2024 (a decline of 99.7%).
- Per Business Quant data, the three quarters before Q4 2024 came in at $20,000 (Q3 2024), $1,000 (Q2 2024) and $15,000 (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 19.05 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 13.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.56 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 9.64 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.68 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.23 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 5.06 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 12.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.13 Bn |
| 10 | IDEAYA Biosciences | 3.68 Bn | 757.04 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 3,000.00 |
| Sep 30, 2024 | 20,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Mar 31, 2024 | 15,000.00 |
| Dec 31, 2023 | 18,000.00 |
| Sep 30, 2023 | 6.70 Mn |
| Jun 30, 2023 | 160,000.00 |
| Mar 31, 2023 | 468,000.00 |
| Dec 31, 2022 | 200,000.00 |
| Sep 30, 2022 | 3.45 Mn |
| Jun 30, 2022 | 288,000.00 |
| Mar 31, 2022 | 697,000.00 |
| Dec 31, 2021 | 1.10 Mn |
| Sep 30, 2021 | 1.02 Mn |
| Jun 30, 2021 | 1.33 Mn |
| Mar 31, 2021 | 2.92 Mn |
| Dec 31, 2020 | 1.88 Mn |
API Access
IDEAYA Biosciences Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=IDYA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "IDYA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=IDYA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();